Log in

Relevant bibliographies by topics / Cancer neuroendocrine

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Cancer neuroendocrine'

Author: Grafiati

Published: 11 January 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cancer neuroendocrine.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cancer neuroendocrine"

1

Palomares Casasús, Sara, Marcos Rolando Adrianzén, Maria Luisa Spa, et al. "NEUROENDOCRINE BREAST TUMOUR: A CHALLENGING ENTITY." Annals of Mediterranean Surgery 5 (February 22, 2022): 27–32. http://dx.doi.org/10.22307/2603.8706.2022.01.005.

Full text

Abstract:

NEUROENDOCRINE BREAST TUMOUR: A CHALLENGING ENTITY TUMOR NEUROENDOCRINO DE MAMA: UNA ENTIDAD DESAFIANTE Neuroendocrine breast carcinoma is a rare type of breast cancer with neuroendocrine differentiation which is found in around 2-5% of all invasive breast carcinomas. In most cases it is a challenge to get to the right diagnosis due to the sporadic number of cases and the need for special immunochemistry techniques, which are not routinely used. Due to the rare number of cases, it is difficult to update guidelines so that the correct diagnosis and treatment is decided. Our purpose is to presen

APA, Harvard, Vancouver, ISO, and other styles

2

Miura, Kentaro, Kimihiro Shimizu, Shogo Ide, et al. "A Novel Strategy for the Diagnosis of Pulmonary High-Grade Neuroendocrine Tumor." Diagnostics 11, no. 11 (2021): 1945. http://dx.doi.org/10.3390/diagnostics11111945.

Full text

Abstract:

Correctly diagnosing a histologic type of lung cancer is important for selecting the appropriate treatment because the aggressiveness, chemotherapy regimen, surgical approach, and prognosis vary significantly among histologic types. Pulmonary NETs, which are characterized by neuroendocrine morphologies, represent approximately 20% of all lung cancers. In particular, high-grade neuroendocrine tumors (small cell lung cancer and large cell neuroendocrine tumor) are highly proliferative cancers that have a poorer prognosis than other non-small cell lung cancers. The combination of hematoxylin and

APA, Harvard, Vancouver, ISO, and other styles

3

Liu, Jin, Xiaohua Pan, Yan Sun, et al. "Clinicopathological Features and Postoperative Survival Analysis of Gastric Carcinoma with Neuroendocrine Differentiation." Journal of Oncology 2022 (August 17, 2022): 1–9. http://dx.doi.org/10.1155/2022/4440098.

Full text

Abstract:

Objectives. This study aims at investigating the differences of clinicopathological features and postoperative prognosis in three different types of neuroendocrine differentiation-related gastric cancers. Methods. From January 1, 2015 to September 30, 2016, 47 patients diagnosed with neuroendocrine differentiation-related gastric cancers were collected from 1095 patients with gastric cancer who underwent surgical treatment in the Department of Gastrointestinal Surgery, Jiangsu Cancer Hospital. Patients were followed up regularly, and the last follow-up time was October 25, 2021. A total of 38

APA, Harvard, Vancouver, ISO, and other styles

4

Sheikh, Rabeeta, Irfan Haider, Muhammad Sohaib Nadeem, Jawad Latif, Kiran Inam, and Muhammad Fawad UL Qamar. "Neuroendocrine Breast Carcinoma: a Case Series." Pakistan Armed Forces Medical Journal 73, no. 5 (2023): 1404–6. http://dx.doi.org/10.51253/pafmj.v73i5.9418.

Full text

Abstract:

Neuroendocrine breast carcinoma (NEBC) is histologically a rare type of invasive breast cancer. It constitutes only 0.2–0.5% of all invasive breast cancers. In this case series, we are presenting five cases having primary neuroendocrine breast cancers that had been reported at a high-volume cancer centre in Pakistan. In this study, neuroendocrine breast cancer patients at Shaukat Khanum Memorial Cancer Hospital and Research Centre Peshawar were evaluated. We had retrospectively collected information on demographic characteristics of our patients, physical examination, radiological findings, su

APA, Harvard, Vancouver, ISO, and other styles

5

Bajetta, Emilio, Laura Catena, Monika Ducceschi, et al. "Pitfalls in the Diagnosis of Neuroendocrine Tumors: Atypical Clinical and Radiological Findings as Cause of Medical Mistakes." Tumori Journal 95, no. 4 (2009): 501–7. http://dx.doi.org/10.1177/030089160909500416.

Full text

Abstract:

Aims and background Carcinoids are infrequent neoplasms arising from neuroendocrine cells. Due to blurred symptoms and the presence of equivocal diagnostic findings, these tumors are sometimes misdiagnosed. Therefore, increased rates of false neuroendocrine tumors represent an emerging problem in clinical practice. Our aim is to alert clinicians on this matter by supplying them with useful warnings. Methods In the specialized neuroendocrine tumor study Center Centro di Riferimento per lo Studio e la Cura dei Carcinoidi e dei Tumori Neuroendocrini (Ce.Ri.Ca), some patients highly suspected to h

APA, Harvard, Vancouver, ISO, and other styles

6

Safina, S. Z., and A. Z. Isyangulova. "Neuroendocrine prostate cancer." Cancer Urology 19, no. 2 (2023): 94–100. http://dx.doi.org/10.17650/1726-9776-2023-19-2-94-100.

Full text

Abstract:

In Russia, prostate cancer is a common disease with fast increasing incidence. In the vast majority of prostate cancer patients receiving hormone therapy, on average 18–36 months after the start of treatment refractoriness to androgen ablation develops. In 15–20 % of patients, signs of neuroendocrine differentiation may develop.Neuroendocrine prostate cancer is an aggressive variant of castration-resistant prostate cancer with poor prognosis and low survival.Due to the rarity of these types of tumors, specific diagnostic and treatment algorithms have not been developed. As a rule, they are sim

APA, Harvard, Vancouver, ISO, and other styles

7

Tsedenova, K. O., M. I. Komarov, V. B. Matveev, and A. D. Panakhov. "Neuroendocrine urethral cancer." Experimental and Сlinical Urology 11, no. 2 (2019): 38–42. http://dx.doi.org/10.29188/2222-8543-2019-11-2-38-42.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Graca, S., J. Esteves, S. Costa, S. Vale, and J. Maciel. "Neuroendocrine breast cancer." Case Reports 2012, aug09 1 (2012): bcr1220115343. http://dx.doi.org/10.1136/bcr.12.2011.5343.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Siddeek, Rohik Anjum T., Amit Gupta, Krishna Bhukya Sai, et al. "Mixed squamous – neuroendocrine carcinoma of the gallbladder: A case report of a rare pathological entity." Cancer Research, Statistics, and Treatment 7, no. 1 (2024): 121–25. http://dx.doi.org/10.4103/crst.crst_186_23.

Full text

Abstract:

Gallbladder cancers are the most common biliary tract malignancies in the world. Adenocarcinoma constitutes the most common histology in gallbladder cancer. Neuroendocrine neoplasms of the gallbladder account for about 0.5% of all neuroendocrine neoplasms and 2.1% of all gallbladder tumors. They are rare tumors and present with non-specific symptoms such as abdominal pain, weight loss, anorexia, and obstructive jaundice, and, therefore, are often challenging to diagnose and treat. Mixed neuroendocrine-non-neuroendocrine neoplasm is a subtype of neuroendocrine neoplasm. To add to the literature

APA, Harvard, Vancouver, ISO, and other styles

10

Hsu, En-Chi, Meghan A. Rice, Abel Bermudez, et al. "Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1." Proceedings of the National Academy of Sciences 117, no. 4 (2020): 2032–42. http://dx.doi.org/10.1073/pnas.1905384117.

Full text

Abstract:

Resistance to androgen deprivation therapy, or castration-resistant prostate cancer (CRPC), is often accompanied by metastasis and is currently the ultimate cause of prostate cancer-associated deaths in men. Recently, secondary hormonal therapies have led to an increase of neuroendocrine prostate cancer (NEPC), a highly aggressive variant of CRPC. Here, we identify that high levels of cell surface receptor Trop2 are predictive of recurrence of localized prostate cancer. Moreover, Trop2 is significantly elevated in CRPC and NEPC, drives prostate cancer growth, and induces neuroendocrine phenoty

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Cancer neuroendocrine"

1

Vias, Maria. "Neuroendocrine differentiation in hormone resistant prostate cancer cells." Thesis, University of Cambridge, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.612330.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hanna, Fahmy William Fahmy. "Calcitonin and related peptides in mammalian neuroendocrine tumours." Thesis, Queen's University Belfast, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.295357.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Bryant, Jennifer. "Neuroendocrine and epithelial markers of small cell lung cancer." Thesis, University of Manchester, 2015. https://www.research.manchester.ac.uk/portal/en/theses/neuroendocrine-and-epithelial-markers-of-small-cell-lung-cancer(c7c51e2c-6443-4021-b2ff-469966cd10b6).html.

Full text

Abstract:

Small cell lung cancer (SCLC) is an extremely aggressive disease characterized by early metastasis and acquired resistance to therapy. SCLC is distinguished by its neuroendocrine (NE) component; the role of which is not fully understood in metastasis and response to therapy. Patients respond exceptionally well to first round chemotherapy; however, relapse with therapy-resistant tumours is virtually inevitable. Hypoxic regions within tumours can contribute towards metastasis and therapy resistance, highlighting hypoxia-targeted therapy as a novel approach for improving treatment for SCLC patien

APA, Harvard, Vancouver, ISO, and other styles

4

Poiraudeau, Loïc. "Identification de nouvelles cibles thérapeutiques dans le cancer neuroendocrine de la prostate." Electronic Thesis or Diss., université Paris-Saclay, 2023. http://www.theses.fr/2023UPASL143.

Full text

Abstract:

Le cancer de la prostate est le cancer le plus fréquent chez l'homme et il constitue la deuxième cause de mortalité par cancer chez l'homme dans les pays industrialisés. Le traitement systémique de ces cancers repose sur une déprivation androgénique par castration chirurgicale ou pharmacologique. Le cancer de la prostate métastatique résistant à la castration (mCRPC) est traité par des inhibiteurs de la voie des androgènes (ARPI). Cependant, environ un tiers des patients ne sont pas sensibles à ces médicaments et les autres, sensibles initialement, développent malheureusement une résistance se

APA, Harvard, Vancouver, ISO, and other styles

5

Гирявенко, Наталія Іванівна, Наталья Ивановна Гирявенко, Nataliia Ivanivna Hyriavenko, et al. "Synchronous case of the primary neuroendocrine cancer of fallopian tube and serous papillary cancer of ovary." Thesis, Springer, 2019. http://essuir.sumdu.edu.ua/handle/123456789/75206.

Full text

Abstract:

Neuroendocrine tumours commonly occur in the gastrointestinal tract and lungs. They rarely were found in the genital organs. There are a few data about this neoplasia in the fallopian tubes, which is accidentally identified during the morphological study. The aim of our investigation was to demonstrate the case of the primary neuroendocrine cancer of the fallopian tube in combination with the serous papillary cancer of the ovary.

APA, Harvard, Vancouver, ISO, and other styles

6

Balabanova, Silviya. "The neuroendocrine-like phenotype of gastric myofibroblasts and its significance in cancer." Thesis, University of Liverpool, 2012. http://livrepository.liverpool.ac.uk/6453/.

Full text

Abstract:

Cell-cell communication, and specifically epithelial-mesenchymal signalling, is a key factor determining normal tissue development and organisation in hollow organs such as gastrointestinal tract. Mechanisms governing normal epithelial-mesenchymal communication have been studied for many years, but the changes occurring during tissue damage, infection and inflammation, and in cancer, remain unclear. Myofibroblasts are recognised as key mesenchymal cells involved in this communication in health and in disease. Myofibroblasts produce and secrete many proteins responsible for the assembly of extr

APA, Harvard, Vancouver, ISO, and other styles

7

Bari, Muhammad Furqan. "Biomarkers for the classification of high grade neuroendocrine lung cancers." Thesis, University of Warwick, 2012. http://wrap.warwick.ac.uk/56420/.

Full text

Abstract:

In the management of lung cancer the most important step beyond establishing the presence a malignant tumour is identifying whether the tumour is small cell lung cancer (SCLC) or one of the variants of non-small cell carcinoma (NSCLC), which includes adenocarcinoma (AD), squamous (SCC), large cell carcinoma (LCC), large cell neuroendocrine carcinoma (LCNEC), typical carcinoids (TC) and atypical carcinoids (AT). SCLC is a high grade neuroendocrine tumour which usually presents as central mass. These tumours are not usually amenable to curative surgical resection and are treated primarily by che

APA, Harvard, Vancouver, ISO, and other styles

8

McWhinney, Sarah Renee. "Role of tumor suppressor genes in neuroendocrine neoplasias and cardiovascular disease." Columbus, Ohio : Ohio State University, 2005. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1133373765.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Goodin, Jeremy Lee. "Characterization of Gene Expression During Adenosine 3':5'-Cyclic Monophosphate Induced Neuroendocrine Differentiation in Human Prostatic Adenocarcinoma." Diss., Virginia Tech, 2002. http://hdl.handle.net/10919/26791.

Full text

Abstract:

The LNCaP cell line is a versatile and useful model that is suitable for the study of human prostate cancer in vitro. The elevation of LNCaP intracellular cAMP levels through the addition of membrane permeable cAMP analogues, phosphodiesterase inhibitors, adenylate cyclase activators, or components of the cAMP signal transduction pathway can induce reversible neuroendocrine differentiation. Elucidation of those genes that are differentially expressed between undifferentiated prostate cancer cells and prostate cancer cells that have been induced to differentiate may present new insights for t

APA, Harvard, Vancouver, ISO, and other styles

10

Chen, Ruiqi. "Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine prostate cancer." Thesis, University of British Columbia, 2017. http://hdl.handle.net/2429/62099.

Full text

Abstract:

Treatment-induced neuroendocrine (NE) prostate cancer (t-NEPC) is an aggressive subtype of prostate cancer (PCa) that can arise as a consequence of rigorous androgen receptor pathway inhibition (ARPI) therapies now used to treat castration resistant disease (CRPC). While the PI3K/AKT pathway has been investigated as a co-therapeutic target with ARPI for advanced prostate adenocarcinoma, whether this strategy has implications on t-NEPC progression remains unknown. Findings from this work indicate that PI3K/AKT inhibition alone reduces protein expression of the RE-1 silencing transcription fact

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Cancer neuroendocrine"

1

Ito, Takaaki. Differentiation and proliferation of pulmonary neuroendocrine cells. Urban & Fischer, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Khayat, Eric. Tumeurs neuroendocrines digestives et médecine nucléaire. Editions médicales internationales, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

G, Maldonado Jonathon, and Cervantes Mikayla K, eds. Small cell carcinomas: Causes, diagnosis and treatment. Nova Science, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Maldonado, Jonathon G. Small cell carcinomas: Causes, diagnosis and treatment. Nova Biomedical Books, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Maldonado, Jonathon G., and Mikayla K. Cervantes. Small cell carcinomas: Causes, diagnosis and treatment. Nova Biomedical Books, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Rezaei, Nima, ed. Neuroendocrine and Oral Cancers: An Interdisciplinary Approach. Springer Nature Switzerland, 2025. https://doi.org/10.1007/978-3-031-87449-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Walsh, Bob. Good Looking Cancer: Neuroendocrine Cancer. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Walsh, Bob. Neuroendocrine Cancer: What You Need to Know about This Deadly Cancer. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Pisegna, Joseph R. Management of Pancreatic Neuroendocrine Tumors. Springer New York, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Pisegna, Joseph R. Management of Pancreatic Neuroendocrine Tumors. Springer, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Cancer neuroendocrine"

1

Güler, E. Nilüfer, Murat Fani Bozkurt, Serdar Ozbas, and Suayib Yalcin. "Thyroid Cancer." In Neuroendocrine Tumours. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45215-8_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hellman, Per, Olov Norlén, Peter Stålberg, and Kosmas Daskalakis. "Thyroid Cancer." In Neuroendocrine Tumours. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-56968-5_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ciltas, Aydin, Yusuf Gunaydin, and Mustafa Benekli. "Medullary Thyroid Cancer." In Neuroendocrine Tumours. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45215-8_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Gall, Victor A., and Amanda M. Laird. "Medullary Thyroid Cancer." In Neuroendocrine Tumors. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-62241-1_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Laçin, Şahin, and Suayib Yalcin. "Medullary Thyroid Cancer." In Neuroendocrine Tumours. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-56968-5_23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Duran, Ignacio, and Lillian L. Siu. "Neuroendocrine Carcinoma." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_4029-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Schmitt-Graeff, Annette. "Neuroendocrine Neoplasms." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_4032-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Duran, Ignacio, and Lillian L. Siu. "Neuroendocrine Carcinoma." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_4029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Schmitt-Graeff, Annette. "Neuroendocrine Neoplasms." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_4032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Duran, Ignacio, and Lillian L. Siu. "Neuroendocrine Carcinoma." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_4029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cancer neuroendocrine"

1

Souto, Andreza Karine de Barros Almeida, Poliana Bergamaschine Giovani Blasi, Brenda Fabiola Delgado Taboada, Fernanda Teresa Lima, Bernardo Garicochea, and Cristiano Augusto Andrade de Resende. "NEUROENDOCRINE CARCINOMA OF THE BREAST AND ILEUM IN A PATIENT WITH BRCA2 PATHOGENIC VARIANT – ONCOLOGIC AND GENETIC CONSIDERATIONS DERIVED FROM A CASE REPORT." In Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2076.

Full text

Abstract:

Background: Neuroendocrine neoplasms (NENs) are a heterogeneous group of neoplasms. Most frequently, they occur in the digestive system, and breast neuroendocrine tumors constitute less than 1% of all of them. Germline mutations can increase the risk of developing tumors and predispose to hereditary cancer syndromes. Some NENs are well-established components of common hereditary syndromes. Recently, whole genomic sequencing revealed that 17% of apparently sporadic pancreatic NENs carried germline mutations, including DNA repair genes, such as BRCAs. It is well known that this gene plays a role

APA, Harvard, Vancouver, ISO, and other styles

2

Aldanbara, H. "Cutan metastases of neuroendocrine cancer (NET)." In Abstract- und Posterband – 91. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Welche Qualität macht den Unterschied. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1710902.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Puca, Loredana, Dong Gao, Myriam Kossai, et al. "Abstract 3844: Targeting EZH2 in neuroendocrine prostate cancer." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-3844.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dardenne, Etienne, Himisha Beltran, Kaitlyn Gayvert, et al. "Abstract 887: N-Myc drives neuroendocrine prostate cancer." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-887.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Marhold, Maximilian, Erwin Tomasich, Simon Udovica, et al. "Abstract 2407: Neuroendocrine and luminal progenitors drive cancer progression in prostate cancer." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2407.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ferguson, Alison M., Bhavneet Bhinder, Vincenza Conteduca, et al. "Abstract 134: Immunogenomic landscape of neuroendocrine prostate cancer (NEPC)." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ferguson, Alison M., Bhavneet Bhinder, Vincenza Conteduca, et al. "Abstract 134: Immunogenomic landscape of neuroendocrine prostate cancer (NEPC)." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sanders, Danielle N., Magdalena Grabowska, and Robert Matusik. "Abstract B23: Neuroendocrine differentiation in prostate cancer and development." In Abstracts: Eighth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 13-16, 2015; Atlanta, Georgia. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7755.disp15-b23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Miller, M. A., A. J. Kumar, W. Shi, J. Karunamuni, G. Chen, and M. M. Fuster. "Spontaneous Regression of Neuroendocrine Lung Cancer: A Case Report." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Vieira, Juliana Sofia Silva, and Paula Karolyne Simões Mello. "Unresectable malignant gallbladder neoplasm." In V Seven International Multidisciplinary Congress. Seven Congress, 2024. http://dx.doi.org/10.56238/sevenvmulti2024-131.

Full text

Abstract:

Gallbladder cancer often arises from somatic mutations in cells of the biliary epithelium, which can be precipitated by chronic inflammation (as in chronic cholelithiasis and cholecystitis), infections (e.g., by Salmonella spp. or Helicobacter spp.), and exposure to carcinogens. Adenocarcinomas represent more than 90% of gallbladder cancer cases, with other histological subtypes including squamous cell carcinomas, adenosquamous carcinomas, and neuroendocrine tumors.

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cancer neuroendocrine"

1

Hu, Chang-Deng, Xuehong Deng, and Gyeon Oh. Targeting Neuroendocrine Differentiation for Prostate Cancer Radiosensitization. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada613326.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Evans, Christopher P. Castration Induced Neuroendocrine Mediated Progression of Prostate Cancer. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada492892.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Evans, Christopher P. Castration-Induced Neuroendocrine Mediated Progression of Prostate Cancer. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada446371.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Huang, Jiaoti. The Function of Neuroendocrine Cells in Prostate Cancer. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada580194.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Huang, Jiaoti. The Function of Neuroendocrine Cells in Prostate Cancer. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada590965.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Huang, Jiaoti. The Function of Neuroendocrine Cells in Prostate Cancer. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada604606.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Huang, Jiaoti. The Function of Neuroendocrine Cells in Prostate Cancer. Defense Technical Information Center, 2015. http://dx.doi.org/10.21236/ada621366.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Evans, Christopher P. Castration Induced Neuroendocrine Mediated Progression of Prostate Cancer. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada476920.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Huang, Jiaoti. Function of PTP1B in Neuroendocrine Differentiation of Prostate Cancer. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada481731.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Kim, Isaac. Neuroendocrine Differentiation in Prostate Cancer: Role of Bone Morphogenetic Protein-6 and Macrophages. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada555480.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!